ORLANDO, Fla.--(BUSINESS WIRE)--A research team from the University of Central Florida and Hesperos, a pioneer in human-on-a-chip technology, has developed the first human model to study the effects ...
SEATTLE, Oct. 29, 2025 /PRNewswire/ -- CounterX Therapeutics, Inc., a biotechnology company focused on developing novel antibody therapeutics and vaccines to address opioid overdose and dependence, ...
Large reductions in the incidence of simulated cardiac arrest caused by potentially lethal doses of fentanyl or carfentanil were observed following a single IN dose of OPVEE compared to a single dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback